• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » BioCity Scotland secures former MSD site

BioCity Scotland secures former MSD site

January 18, 2012
CenterWatch Staff

Newly-formed BioCity Scotland, a centralized base for growing bioscience, pharameutical, med tech and health companies, will set up house in the former-MSD research facility at Newhouse, which it acquired Jan. 11.

A joint venture between BioCity Nottingham and Roslin BioCentre, BioCity Scotland will be 15 miles from Glasgow and 33 miles from Edinburgh, a central location for growing companies in Scotland.

The 130,000-square-foot facility consists of purpose-built labs and offices on 23 acres and is capable of supporting pre-clinical drug discovery and development by a range of independent companies. It is equipped with administrative and conference facilities to provide support and networking capabilities for client companies.

BioCity Scotland will provide access to a range of state-of-the-art equipment, available to rent at competitive rates. On-site business support will allow companies to tap into funding opportunities to assist their growing business needs.

“BioCity Scotland is much more than a property proposition—it will be a unique, vibrant community of scientific companies,” said Louis J. Nisbet, chairman of BioCity Scotland. “BioCity Nottingham's success in nurturing and growing over 70 new companies since 2003, and Roslin's expertise in life sciences innovation and facilities management makes this team the perfect commercial partnership."

Upcoming Events

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

  • 06May

    The World of Post-COVID-19 Clinical Trials: How to Prepare for What’s Coming Next

  • 25May

    How Can the Accelerated Availability of Pfizer-BioNTech’s COVID-19 Vaccine be Replicated?

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Clinical-Trial-Brainstorming

    FDA, Industry Tackle Problem of Including Older Adults in Trials

  • ClinicalTrialNetwork-360x240.png

    National Community-Based Research Network Would Improve Reach of Trials

  • Bottleneck-360x240.png

    Sites Face Trials Bottleneck After Pandemic, But Also Opportunities

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Genetic Research and IBC Oversight Requirements

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing